(Q53285861)

13 May 2018

title

Low frequency of PIK3CA gene mutations in hepatocellular carcinoma in Chinese population. (English)

1 reference

13 May 2018

author name string

Xun Li

1

1 reference

13 May 2018

Quanbao Zhang

2

1 reference

13 May 2018

Wenting He

3

1 reference

13 May 2018

Wenbo Meng

4

1 reference

13 May 2018

Jun Yan

5

1 reference

13 May 2018

Lei Zhang

6

1 reference

13 May 2018

Xiaoliang Zhu

7

1 reference

13 May 2018

Tao Liu

8

1 reference

13 May 2018

Yumin Li

9

1 reference

13 May 2018

Zhongtian Bai

10

1 reference

13 May 2018

publication date

12 June 2011

1 reference

13 May 2018

Pathology Oncology Research

published in

1 reference

13 May 2018

volume

18

1 reference

13 May 2018

issue

1

1 reference

13 May 2018

page(s)

57-60

1 reference

13 May 2018

A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

PI3K-Akt pathway: its functions and alterations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

PIK3CA mutations and copy number gains in human lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

PIK3CA mutation and amplification in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

PIK3CA mutation status in Japanese esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

PIK3CA mutation associates with improved outcome in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

The prevalence of PIK3CA mutations in gastric and colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

Mutations of PIK3CA in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

PIK3CA alterations in Middle Eastern ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

Functional analysis of PIK3CA gene mutations in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

Human tumor mutants in the p110alpha subunit of PI3K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

Rare cancer-specific mutations in PIK3CA show gain of function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

Prevention and control of hepatitis B in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9416-5

Rare PIK3CA hotspot mutations in carcinomas of the biliary tract

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21667306

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21667306

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21667306

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12253-011-9416-5

1 reference

13 May 2018

1 reference

13 May 2018